What Is Cancer Treatment?

Cancer treatment is the collection of medical interventions applied to eliminate, reduce, or control malignant disease in a patient. It encompasses surgery, radiation therapy, systemic drug therapies, and a growing set of biological and cellular approaches, frequently combined within a single care plan. The goal of treatment varies by intent: curative therapy aims to eradicate all detectable disease; adjuvant therapy reduces the risk of recurrence after primary treatment; neoadjuvant therapy shrinks a tumor before surgery; and palliative therapy alleviates symptoms and extends survival when cure is not achievable.

Treatment selection is guided by tumor type, anatomical location, molecular subtype, disease stage, and patient performance status. Multidisciplinary tumor boards, composed of oncologists, surgeons, radiologists, pathologists, and supportive care specialists, coordinate individualized plans. The National Cancer Institute treatment portal documents approved regimens across all cancer types and updates its guidance as clinical trial data mature.

Surgical Oncology

Surgery remains the definitive treatment for most solid tumors diagnosed before regional or distant spread. The primary goal of oncological surgery is achieving clear resection margins, meaning no detectable tumor cells at the tissue boundary. Sentinel lymph node biopsy, introduced in the 1990s for melanoma and breast cancer, allows surgeons to assess the nearest draining lymph node for metastatic involvement without removing the full nodal basin, substantially reducing morbidity. Minimally invasive approaches, including laparoscopy, robotic-assisted surgery, and video-assisted thoracoscopic surgery, achieve equivalent oncological outcomes with reduced recovery times for appropriate tumor locations. Intraoperative imaging, including fluorescence-guided surgery using near-infrared dyes, is an active area of development for real-time margin assessment.

Radiation Therapy

Radiation therapy uses ionizing radiation to damage the DNA of tumor cells, triggering cell death or permanent loss of proliferative capacity. External beam radiation therapy (EBRT) delivers photon or particle beams from a linear accelerator, with intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) shaping dose distributions to spare adjacent normal structures. Stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) concentrate very high doses in a small number of fractions, enabling ablative treatment of lung, liver, and brain tumors. Proton beam therapy exploits the Bragg peak to deposit most of its energy within the tumor volume while reducing exit dose, which is valuable for pediatric tumors near critical structures. Brachytherapy places radioactive seeds or applicators directly within or adjacent to a tumor, as used in prostate and cervical cancer. As reviewed in radiation therapy advances across cancer types, modern radiation planning uses CT, MRI, and PET-based contouring combined with adaptive replanning to account for tumor shrinkage and organ motion during a course of treatment.

Systemic Therapy and Personalized Medicine

Systemic therapies circulate through the bloodstream to reach tumor cells throughout the body. Traditional cytotoxic chemotherapy acts on all rapidly dividing cells; targeted agents inhibit specific mutated oncoproteins such as EGFR, ALK, or BRAF. Immunotherapy with checkpoint inhibitors, particularly anti-PD-1 and anti-CTLA-4 antibodies, has produced durable responses in melanoma, lung, renal, and bladder cancers by releasing tumor-induced suppression of T-cell activity. Hormonal therapies suppress androgen signaling in prostate cancer and estrogen signaling in hormone receptor-positive breast cancer. Personalized medicine matches specific drugs to the molecular profile of an individual tumor identified by high-throughput DNA sequencing, and genomics-based treatment matching programs are now embedded in major cancer centers to direct patients toward targeted agents or clinical trials when standard options have been exhausted.

Applications

Cancer treatment has applications in a range of fields, including:

• Treatment planning software and dose calculation for radiation oncology
• Surgical robotics and image-guided navigation systems
• Drug delivery systems including nanoparticle formulations and antibody-drug conjugates
• Biomarker testing platforms for therapy selection
• Clinical trial design and adaptive trial methodology
• Palliative and supportive care technology including pain management devices